References

  1. Herbort Carl P, Mochizuki Manabu. Vogt-Koyanagi-Harada disease: inquiry into the genesis of a disease name in the historical context of Switzerland and Japan. Int Ophthalmol. 2007 Apr-Jun; 27(2-3):67-79. PubMed | Google Scholar

  2. Alaoui FZ. Syndrome de Vogt-Koyanagi-Harada à propos de huit cas. La Revue de Médecine Interne. April 2007; 28(4) :Pages 250-254. Google Scholar

  3. Abu El-Asrar AM, Al-Kharashi AS, Aldibhi H, Al-Fraykh H, Kangave D. Vogt-Koyanagi-Harada disease in children. Eye (Lond). 2008 Sep; 22(9): 1124-31. PubMed | Google Scholar

  4. Rao NA. Pathology of Vogt-Koyanagi-Harada disease. Int Ophthalmol. 2007 Apr-Jun;27(2-3):81-5. PubMed | Google Scholar

  5. Abad S, Monnet D, Caillat-Zucman S et al. Characteristics of Vogt-Koyanagi-Harada disease in a French cohort: ethnicity, systemic manifestations, and HLA genotype data. Ocul Immunol Inflamm. 2008 Jan-Feb;16(1):3-8. PubMed | Google Scholar

  6. Al Dousary S. Auditory and vestibular manifestations of Vogt-Koyanagi-Harada disease. J Laryngol Otol. 2011 Feb; 125 (2):138-41. PubMed | Google Scholar

  7. Rao NA, Sukavatcharin S, Tsai JH. Vogt-Koyanagi-Harada disease diagnostic criteria. Int Ophthalmol. 2007 Apr-Jun;27(2-3):195-9. PubMed | Google Scholar

  8. Zhao C, Zhang MF, Dong FT et al. Spectral domain optical coherence tomography of Vogt-Koyanagi-Harada disease: novel findings and new insights into the pathogenesis. Chin Med Sci J. 2012 Mar;27(1):29-34. PubMed | Google Scholar

  9. Errera MH, Fardeau C, Cohen D et al. Effect of the duration of immunomodulatory therapy on the clinical features of recurrent episodes in Vogt-Koyanagi-Harada disease. Acta Ophthalmol. 2011 Jun; 89(4):e357-66. PubMed | Google Scholar